Examining the Dose–Response Relationship in the Veterans Health Administration’s MOVE!® Weight Management Program: A Nationwide Observational Study

Chan, Stephanie H.; Raffa, Susan D.

doi:10.1007/s11606-017-3992-3

Cited by 35 publications

(52 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Program and weight outcomes. 12 Breland and colleagues examine the prevalence of obesity among key populations of male and female Veterans, including racial/ ethnic and comorbidity sub-populations, 2 while Estabrooks and colleagues assess the impact of a community-based weight loss program among non-Veterans. 13 VA HSR&D believes this Supplement will make a significant contribution to establishing an integrated approach to weight management in the VHA, one that will better help Veterans obtain effective, patient-centered interventions to assist them in reaching a healthier weight.…”

Section: Creating Integrated Weight Management Solutionsmentioning

confidence: 99%

Improving Weight Management among Veterans

Atkins

2017

J GEN INTERN MED

View full text Add to dashboard Cite

Section: Creating Integrated Weight Management Solutionsmentioning

confidence: 99%

Improving Weight Management among Veterans

Atkins

2017

J GEN INTERN MED

View full text Add to dashboard Cite

“…Program in the Veterans Affairs Healthcare system. 51 The cost of high attrition, however, appears to be much lower in a scalable intervention such as WAW due to low resource use (for example, no in- person staff time per participant initiating enrollment). Our findings also point to robust cost-effectiveness across participants from different racial and ethnic groups.…”

Section: Discussionmentioning

confidence: 99%

Cost effectiveness and return on investment of a scalable community weight loss intervention

Michaud

You

Wilson

et al. 2017

Preventive Medicine

View full text Add to dashboard Cite

This study assessed the lifetime health and economic consequences of an efficacious scalable community weight loss program for overweight and obese adults. We applied a state-transition Markov model to project lifetime economic outcome (US dollar) and the degree of disease averted as a result of a weight loss intervention, compared with no intervention, from a payer perspective. Effect sizes of the intervention on weight loss, by sex, race and ethnicity, and body mass index (BMI) of participants, were derived from a 12-month community program. Relative risk of diseases across BMI levels and other parameters were informed by the literature. A return on investment (ROI) analysis was conducted to present the overall cost-benefit of the program. Simulation results showed that among 33,656 participants and at a cost of $2.88 million, the program was predicted to avert (with a corresponding estimated medical costs saved of) 78 cases of coronary heart disease ($28 million), 9 cases of strokes ($971,832), 92 cases of type 2 diabetes ($24 million), 1 case of colorectal cancer ($357,022), and 3 cases of breast cancer ($483,259) over the participant lifetime. The estimated medical costs saved per participant was $1,403 ($1,077 of African American men and $1,532 of Hispanic men), and the ROI was $16.7 ($12.8 for African American men and $18.3 for Hispanic men) for every $1 invested. We concluded that a scalable efficacious community weight loss program provides a cost-effective approach with significant ROI, which will assist informed decisions for future adoption and dissemination.

show abstract

“…were those described by the national MOVE! program in prior literature . In brief, we identified patients with administrative visits with the stop codes 372 or 373 (which were associated with MOVE!…”

Section: Methodsmentioning

confidence: 99%

Patient Characteristics Associated with Receipt of Prescription Weight‐Management Medications Among Veterans Participating in MOVE!

Thomas

Waring

Ameli

et al. 2019

Obesity

View full text Add to dashboard Cite

Objective: Weight-management medications (WMM) are recommended for the treatment of obesity. This study examined characteristics associated with initial receipt of WMM among eligible veterans in the first year following enrollment in the Veterans Health Administration (VHA) MOVE! behavioral weight-management program. Methods: We conducted a retrospective cohort study of VHA patients with obesity or overweight and obesity-related comorbidities who enrolled in MOVE! from October 2013 to September 2016 (N =153,939). Multivariable logistic regression models estimated predictors of having a filled prescription for WMM and for orlistat. Results: A total of 1.1% of these veterans received WMM. The most common WMM included orlistat (70.4%), phentermine/topiramate (11.2%), and bupropion/naltrexone (9.7%). Female sex, higher BMI, obstructive sleep apnea, osteoarthritis, depression, lower back pain, and alcohol abuse were associated with greater odds of use of WMM, whereas age over 65 years, Hispanic ethnicity, and required co-payments were associated with lower odds. Among patients receiving WMM, older age, black race, female sex, higher BMI, cardiovascular disease, lower back pain, and congestive heart failure were associated with use of orlistat versus any other WMM. Conclusions: Of patients engaged in MOVE! in the VHA, 1.1% received WMM. WMM are underutilized among veterans. Additional research is needed to understand barriers to incorporating WMM into comprehensive obesity treatment plans.

show abstract

Examining the Dose–Response Relationship in the Veterans Health Administration’s MOVE!® Weight Management Program: A Nationwide Observational Study

Cited by 35 publications

References 25 publications

Improving Weight Management among Veterans

Improving Weight Management among Veterans

Cost effectiveness and return on investment of a scalable community weight loss intervention

Patient Characteristics Associated with Receipt of Prescription Weight‐Management Medications Among Veterans Participating in MOVE!

Contact Info

Product

Resources

About